SURGICAL MANAGEMENT OF DESCENDING AORTIC ATHEROSCLEROTIC ANEURYSMS CONTRADICTS PATHOLOGY ETIOPATHOGENESIS
Surgical management for descending aortic atherosclerotic aneurysms (DAAA) has been agreed to be the major method up to now. At the same time, numerous publications discrediting the opinion are known. This article presents the data based on examinations of three groups of patients treated either with medicines and (or) by surgeries made in 2 and in 4 years after the treatment. The data show that the DAAA surgical management cannot be the major one as it is not based on the pathology etiopathogenesis. Thus, the concomitant disease is often (over 53.8%) the major cause of lethality in every group. The aneurysm rupture leads to death twice rarer than the co-morbid pathology. The aneurysm rupture associated lethality after a surgery with the operational lethality added make those lethality values comparable with the conservative therapy associated ones. Due to the abovementioned and to the fact that surgeries are possible in 45% of patients only an etiopathogenically grounded pharmacological therapeutic technique should be developed.